Profiel
Dale E.
Johnson is the founder of Emiliem, Inc. He previously worked as the Vice President-Drug Assessment & Development at Chiron Corp.
He holds a doctorate degree from the University of Michigan and an undergraduate degree from the University of Michigan College of Pharmacy.
Actieve functies van Dale E. Johnson
| Bedrijven | Functie | Begin |
|---|---|---|
Emiliem, Inc.
 Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Oprichter | - |
Eerdere bekende functies van Dale E. Johnson
| Bedrijven | Functie | Einde |
|---|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Opleiding van Dale E. Johnson
| University of Michigan | Doctorate Degree |
| University of Michigan College of Pharmacy | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Emiliem, Inc.
Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Health Technology |
